Should all patients with an acute myocardial infarction be referred for direct PTCA?

Heart

Volumn 90, Issue 11, 2004, Pages 1352-1357

  De Jaegere, Peter P ^a   Serruys, Patrick W ^a   Simoons, Maarten L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; BLEEDING; CARDIOGENIC SHOCK; COMMUNITY HOSPITAL; CORONARY ARTERY BYPASS GRAFT; COST; DEATH; EARLY DIAGNOSIS; FIBRINOLYTIC THERAPY; HEART REINFARCTION; HUMAN; MORBIDITY; MORTALITY; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; PATIENT TRANSFER; REFERRAL AND CONSULTATION; THROMBOLYTIC THERAPY;

EID: 7244231140     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.019091     Document Type: Review

References (20)

1. Chombless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO Monica Project 1985-1990. Circulation 1997;96:3849-59. World Health Organization MONICA project providing detailed information of case fatality rate during various phases of AMI.
2. Rogers W, Canta J, Barron H, et al. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol 2000;35:371-9. Large US registry reporting treatment and outcome of more than 300 000 patients with AMI admitted in more than 1500 hospitals with different infrastructure.
3. Fibrinolytic Therapy Trialists' (FFT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials more than 1000 patients. Lancet 1994;343:311-22. Landmark review of the effect of thrombolysis in placebo controlled randomised studies with more than 1000 patients.
4. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5. Meta-analysis of placebo controlled randomised studies underscoring the key role of time in AMI.
5. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000;283:2686-92. Meta-analysis of the randomised studies comparing pre- and in-hospital thrombolysis. Time reduction saves the myocardium.
6. Grines C, Browne K, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9. One of three randomised studies published at the same time in the same journal comparing PTCA and thrombolysis, which boosted direct PTCA and a new era of infarct management.
7. Zijlstra F, de Boer MJ, Hoorntje J, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4. See reference 6.
8. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. Analysis of 23 randomised comparisons summarising the superiority of direct PTCA in comparison to in-hospital thrombolysis.
9. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Prague-2 Study. Eur Heart J 2003;24:94-104. Immediate transfer for PTCA is safe and lowers mortality in comparison to streptokinase.
10. Anderson H, Nielsen T, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42. Transfer for direct PICA is superior to in-hospital thrombolysis provided transfer is within ≤ 2 hours.
11. Bonnefoy E, Lapostolle F, Leizorowicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-9. Transfer for direct PTCA is not better than pre-hospital thrombolysis with a rescue PTCA option.
12. Topol E, Califf R, George B, et al. Randomized trial of immediate versus delayed elective angioplasty after tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-8. Randomised comparison reporting absence of benefit after a systematic invasive strategy in comparison to a delayed invasive strategy.
13. Simoons M, Arnold A, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate PTCA. Lancet 1988;i:197-203. Randomised study reporting absence of benefit after immediate PTCA.
14. TIMI Study Group. Comparison of invasive and conservative strategies after tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989;320:618-27. Largest randomised study disclosing no benefit of a systematic invasive strategy compared to an ischaemia guided invasive strategy.
15. Scheller B, Hennen B, Hammer B, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003;42:634-41. At variance with the early studies, this randomised study revealed the benefit of routine stenting after thrombolysis.
16. Aversono T, Aversano L, Passamani E, et al. Thrombolysis vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery. JAMA 2002;287:1943-51. Randomised study reporting that direct PTCA is superior to thrombolysis in centres without a PTCA programme or surgical standby provided adequate preparation, training, organisation, and monitoring of procedures.
17. Schomig A, Ndrepepa G, Mehilli J, et al. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 2003;108:1084-8. Clinical pathophysiological study revealing that PTCA is less time sensitive than thrombolysis.
18. Magid D, Calonge B, Rumsfeld J, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolysis. JAMA 2000;284:3131-8. Substudy of the NRMI registry revealing the relation between outcome after direct PTCA and experience, case load, and organisation.
19. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. CAPTIM randomized clinical trial. Circulation 2003;108:2851-6. Subanalysis of the CAPTIM study indicating that thrombolysis is superior to direct PTCA in case of early presentation.
20. Armstrong PW, Collen D, Antmann E. Fibrinolysis for acute myocardial infarction. The future is here and now. Circulation 2003;107:2533-7. Objective paint of view on both thrombolysis and direct PTCA.